Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Income from Continuing Operations (2019 - 2025)

Historic Income from Continuing Operations for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$9.1 million.

  • Biodesix's Income from Continuing Operations rose 1417.42% to -$9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.0 million, marking a year-over-year increase of 824.26%. This contributed to the annual value of -$42.8 million for FY2024, which is 1596.37% up from last year.
  • As of Q3 2025, Biodesix's Income from Continuing Operations stood at -$9.1 million, which was up 1417.42% from -$11.6 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Income from Continuing Operations ranged from a high of -$6.2 million in Q1 2021 and a low of -$18.8 million during Q1 2023
  • Over the past 5 years, Biodesix's median Income from Continuing Operations value was -$11.6 million (recorded in 2025), while the average stood at -$12.1 million.
  • As far as peak fluctuations go, Biodesix's Income from Continuing Operations tumbled by 29234.66% in 2021, and later skyrocketed by 4404.5% in 2023.
  • Quarter analysis of 5 years shows Biodesix's Income from Continuing Operations stood at -$13.2 million in 2021, then dropped by 24.78% to -$16.4 million in 2022, then soared by 44.05% to -$9.2 million in 2023, then increased by 8.67% to -$8.4 million in 2024, then fell by 8.62% to -$9.1 million in 2025.
  • Its last three reported values are -$9.1 million in Q3 2025, -$11.6 million for Q2 2025, and -$10.8 million during Q1 2025.